CJC-1295 With DAC CJC-1295 with DAC (Drug Affinity Complex) is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). It’s designed to stimulate the pituitary gland to release more human growth hormone (hGH) in a prolonged manner. The “DAC” component is a modification that binds to albumin in the blood, extending its half-life from minutes (like natural GHRH) to about 6-8 days, allowing for less frequent dosing. Key Mechanism and Effects How it works: It mimics GHRH, binding to receptors in the pituitary to pulse hGH release. Unlike shorter-acting GHRH analogs (e.g., Mod GRF 1-29), the DAC version provides sustained elevation of hGH and IGF-1 (insulin-like growth factor 1) levels. Reported benefits (based on studies and user reports): Benefit Evidence/Notes Increased muscle growth & fat loss Animal/human studies show 2-10x hGH increase; popular in bodybuilding. Improved recovery & sleep Elevates deep sleep stages via hGH pulses. Anti-aging effects Boosts collagen, skin elasticity; IGF-1 supports tissue repair. Enhanced metabolism May aid fat oxidation without insulin spikes. Dosing (common protocols, not medical advice): Protocol Dosage Frequency Notes Standard 1-2 mg/week 1-2x/week (e.g., Mon/Thu) Subcutaneous injection; split to avoid peaks. Beginner 500-1000 mcg/week Once weekly Start low to assess tolerance. Stacked With Ipamorelin (GHRP) Same schedule Synergistic for GH pulses. Scientific Backing Studies: A key 2006 study (Teichman et al., J Clin Endocrinol Metab) on healthy adults showed CJC-1295 DAC (30-60 mcg/kg weekly) increased mean hGH by 2-10x and IGF-1 by 1.5-3x for up to 28 days, with minimal side effects. No large-scale long-term human trials exist due to its research-chemical status. Comparisons: Peptide Half-Life GH Pulse Style Cost CJC-1295 DAC 6-8 days Sustained elevation $$ CJC-1295 no DAC (Mod GRF) ~30 min Short pulses (needs 3x/day) $ Ipamorelin ~2 hours Pulsatile (GHRP) $$ Risks and Side Effects Common: Water retention, flushing, headaches, fatigue (from prolactin rise), injection site reactions. Serious: Potential insulin resistance, carpal tunnel, or GH-related risks (e.g., acromegaly with abuse). Not FDA-approved for human use; sourced as “research chemical.” Legality: Research-only in most countries (e.g., US); not for human consumption. Banned by WADA for athletes. Sourcing and Purity Often sold lyophilized (2mg vials) from peptide vendors. Test for purity (>98%) via HPLC/MS; avoid underdosed fakes. Reconstitute with bacteriostatic water. Disclaimer: This is for informational purposes only. CJC-1295 is not approved for medical use. Consult a physician before use; self-administration carries health/legal risks. Evidence is mostly preclinical/user-based, not definitive RCTs.
